-
EP3737750
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3737750
| EP3737750 - ALKALINE PHOSPHATASE AGENTS FOR TREATMENT OF NEURODEVELOPMENTAL DISORDERS [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 03.05.2024 Database last updated on 06.07.2024 | |
| Former | Grant of patent is intended Status updated on 29.04.2024 | ||
| Former | Examination is in progress Status updated on 01.03.2024 | ||
| Former | Grant of patent is intended Status updated on 07.01.2024 | ||
| Former | Examination is in progress Status updated on 31.08.2022 | ||
| Former | Request for examination was made Status updated on 16.10.2020 | ||
| Former | The international publication has been made Status updated on 19.07.2019 | Most recent event Tooltip | 03.05.2024 | (Expected) grant | published on 05.06.2024 [2024/23] | Applicant(s) | For all designated states Theriva Biologics, Inc. 9605 Medical Center Drive Suite 270 Rockville, MD 20850 / US | [2023/17] |
| Former [2020/47] | For all designated states Synthetic Biologics, Inc. 9605 Medical Center Drive Suite 270 Rockville, MD 20850 / US | Inventor(s) | 01 /
KALEKO, Michael c/o Theriva Biologics, Inc. 9605 Medical Center Drive Suite 270 Rockville, MD 20850 / US | 02 /
FURLAN FREGUIA, Christian c/o Theriva Biologics, Inc. 9605 Medical Center Drive Suite 270 Rockville, MD 20850 / US | 03 /
CONNELLY, Sheila c/o Theriva Biologics, Inc. 9605 Medical Center Drive Suite 270 Rockville, MD 20850 / US | [2024/23] |
| Former [2020/47] | 01 /
KALEKO, Michael c/o Synthetic Biologics, Inc. 9605 Medical Center Drive Suite 270 Rockville, MD 20850 / US | ||
| 02 /
FURLAN FREGUIA, Christian c/o Synthetic Biologics, Inc. 9605 Medical Center Drive Suite 270 Rockville, MD 20850 / US | |||
| 03 /
CONNELLY, Sheila c/o Synthetic Biologics, Inc. 9605 Medical Center Drive Suite 270 Rockville, MD 20850 / US | Representative(s) | Grund, Martin, et al Grund Intellectual Property Group Patentanwälte und Solicitor PartG mbB Steinsdorfstraße 2 80538 München / DE | [2024/23] |
| Former [2020/47] | Grund, Martin, et al Grund Intellectual Property Group Patentanwalt und Solicitor PartG mbB Postfach 44 05 16 80754 München / DE | Application number, filing date | 19739158.4 | 08.01.2019 | [2020/47] | WO2019US12671 | Priority number, date | US201862615227P | 09.01.2018 Original published format: US 201862615227 P | US201862679310P | 01.06.2018 Original published format: US 201862679310 P | [2020/47] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019139891 | Date: | 18.07.2019 | Language: | EN | [2019/29] | Type: | A1 Application with search report | No.: | EP3737750 | Date: | 18.11.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.07.2019 takes the place of the publication of the European patent application. | [2020/47] | Type: | B1 Patent specification | No.: | EP3737750 | Date: | 05.06.2024 | Language: | EN | [2024/23] | Search report(s) | International search report - published on: | US | 18.07.2019 | (Supplementary) European search report - dispatched on: | EP | 14.10.2021 | Classification | IPC: | C12N9/16, C12Q1/42, G01N33/68, A23L29/00, A61K35/741, A61P25/18, A61K38/46 | [2021/46] | CPC: |
C12N9/16 (EP);
A61K38/465 (EP,US);
A23L29/06 (EP);
A23L33/10 (EP);
A61K9/0053 (US);
A61P25/00 (US);
A61P25/18 (EP);
C12Y301/03001 (EP);
A01K2207/25 (EP);
|
| Former IPC [2020/47] | C12N9/16, C12Q1/42, G01N33/68, A23L29/00, A61K35/741 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/47] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | ALKALISCHE PHOSPHATASEMITTEL ZUR BEHANDLUNG VON ENTWICKLUNGSSTÖRUNGEN DES NERVENSYSTEMS | [2020/47] | English: | ALKALINE PHOSPHATASE AGENTS FOR TREATMENT OF NEURODEVELOPMENTAL DISORDERS | [2020/47] | French: | AGENTS DE PHOSPHATASE ALCALINE POUR LE TRAITEMENT DE TROUBLES NEURODÉVELOPPEMENTAUX | [2020/47] | Entry into regional phase | 22.07.2020 | National basic fee paid | 22.07.2020 | Search fee paid | 22.07.2020 | Designation fee(s) paid | 22.07.2020 | Examination fee paid | Examination procedure | 22.07.2020 | Examination requested [2020/47] | 27.04.2022 | Amendment by applicant (claims and/or description) | 30.08.2022 | Despatch of a communication from the examining division (Time limit: M04) | 12.10.2022 | Reply to a communication from the examining division | 08.01.2024 | Communication of intention to grant the patent | 01.03.2024 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 29.04.2024 | Fee for grant paid | 29.04.2024 | Fee for publishing/printing paid | 29.04.2024 | Receipt of the translation of the claim(s) | Fees paid | Renewal fee | 18.03.2021 | Renewal fee patent year 03 | 21.01.2022 | Renewal fee patent year 04 | 13.01.2023 | Renewal fee patent year 05 | 17.01.2024 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 31.01.2021 | 03 M06 Fee paid on 18.03.2021 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO2014007229 (TOYO BOSEKI [JP]); | [Y]US2016201110 (MALO MADHU S [US]); | [Y]JP2017192381 (TOSOH CORP); | by applicant | US4196564 | US4196565 | US4247006 | US4250997 | US4268265 | US5317849 | US6572892 | US2006001896 | US7083784 | US2007292523 | US2008020018 | US2008113031 | WO2008135090 | US7712634 | US2010203120 | US2010255087 | US2010297221 | US2011052645 | US8074835 | US2012141585 | US2012141531 | US8398912 | US8440224 | US2013184290 | US8535713 | US2013243873 | US8557294 | US2013287842 | US2013295188 | US2013307962 | US2013330411 | US2014017313 | US8646591 | US2014088202 | US8739812 | US2014227357 | US8810259 | US2014234418 | US8852631 | US2014302132 | US8911777 | US8911788 | WO2015US54606 |